Summary
Cardinal Health Inc. (CAH) filed an 8-K on May 4, 2023, primarily related to the extension of a cooperation agreement with Elliott Associates, L.P. and its affiliates. This amendment to the September 2022 agreement extends its term until at least July 15, 2024, and also extends the term of the Company's Business Review Committee. This suggests continued engagement and a potentially longer-term strategic dialogue between the Company and Elliott. The filing also serves as a notification of the Company's financial results for the quarter ended March 31, 2023, which were released via a press announcement on May 4, 2023. While the 8-K itself doesn't detail these results, it directs investors to the press release (Exhibit 99.1) and upcoming investor webcast scheduled for May 4, 2023, where management will discuss the quarterly performance and provide an updated outlook for the fiscal year ending June 30, 2023. Investors should review these related materials for specific financial performance details.
Key Highlights
- 1Cardinal Health extended its Cooperation Agreement with Elliott Associates, L.P. and affiliates until at least July 15, 2024.
- 2The Business Review Committee's term has been extended to align with the Cooperation Agreement's new end date.
- 3The 8-K filing announces the release of Q4 2023 earnings results on May 4, 2023.
- 4A webcast is scheduled for May 4, 2023, to discuss the Q4 results and provide an updated FY2023 outlook.
- 5The amendment to the Cooperation Agreement does not alter its existing terms, only its duration.
- 6Investors are directed to Exhibit 99.1 (press release) and the company's investor relations website for detailed financial information and webcast access.